Ушбу иш иқтибос қилган ишлар

76 та иш

Иш: TIMES TO ACT. Italian-Spanish-Polish-Uzbek Expert Forum Position Paper 2022. Dyslipidemia and arterial hypertension: The two most important and modifiable risk factors in clinical practice

1. Yaşlı Kadınlarda Üreme Sağlığı

   Kokanalı, Demet, Engin Üstün, Yaprak

   Препринт144 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.053922

2. 2018 ESC/ESH Guidelines for the management of arterial hypertension

   Bryan Williams, Giuseppe Mancia, Wilko Spiering +95

   Мақола201816 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.072395

3. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>

   François Mach, Colin Baigent, Alberico L. Catapano +87

   Мақола20197 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.057803

4. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

   François Mach, Colin Baigent, Alberico L. Catapano +96

   Шарҳ мақола20193 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.057765

5. Adherence in Hypertension

   Michel Burnier, Brent M. Egan

   Шарҳ мақола20193 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.091089

6. Nonadherence to antihypertensive drugs

   Tadesse Melaku Abegaz, Abdulla Shehab, Eyob Alemayehu Gebreyohannes +2

   Шарҳ мақола20173 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.185230

7. Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials

   David S Wald, Malcolm Law, Joan K. Morris +2

   Шарҳ мақола20093 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.295707

8. Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia

   Pablo Lázaro, Leopoldo Pérez de Isla, Gerald F. Watts +10

   Мақола20172 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.011189

9. A systematic review and meta-analysis on the therapeutic equivalence of statins

   T.-C. Weng, Yea Huei Kao Yang, Sung‐Jan Lin +1

   Шарҳ мақола20092 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.057648

10. Hypertension and Drug Adherence in the Elderly

    Michel Burnier, Erietta Polychronopoulou, Grégoire Wuerzner

    Шарҳ мақола20202 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.091096

11. Italian Society of Arterial Hypertension (SIIA) Position Paper on the Role of Renal Denervation in the Management of the Difficult-to-Treat Hypertensive Patient

    Rosa María Bruno, Stefano Taddei, Claudio Borghi +10

    Шарҳ мақола20202 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.211319

12. Noncommunicable diseases, climate change and iniquities: What COVID‐19 has taught us about syndemic

    Agostino Di Ciaula, Marcin Krawczyk, Krzysztof J. Filipiak‬ +3

    Шарҳ мақола20212 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.377310

13. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.547962

14. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.547963

15. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.547964

16. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.547965

17. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.547966

18. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.547967

19. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.547968

20. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.547969

21. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.547970

22. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.547971

23. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.547972

24. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.547973

25. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.547974